Pure Global AI
ANVISA registration 80048490105Valid until May 12, 2035

17-HYDROXYPROGESTERONE (17-OHP) - NEONATAL SCREENING

ANVISA Registration Number: 80048490105USA DIAGNOSTICA LTDAMONOBIND, INCRisk Class III
Verified
Device names
Technical name
17-HYDROXYPROGESTERONE (17-OHP) - NEONATAL SCREENING
View exact technical-name matches →
PT: 17-HIDROXIPROGESTERONA (17-OHP) - TRIAGEM NEONATAL
Commercial name
17 alfa-OH Progesterona Test System – ELISA
View exact commercial-name matches →
Risk class
Class III
Registration details
Registration Number
80048490105
Process Number
25351434132202468
CNPJ
02330159000108
Company information
Registration Holder
USA DIAGNOSTICA LTDA
Manufacturer
MONOBIND, INC
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
May 12, 2025
Validity
12/05/2035
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for 17-HYDROXYPROGESTERONE (17-OHP) - NEONATAL SCREENING in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80048490105 and manufactured by MONOBIND, INC. The registration is held by USA DIAGNOSTICA LTDA with validity until May 12, 2035.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.